Beyond Titer: Accelerating Biologics Process Development with Integrated Product Quality Analysis

Webinar Date: September 08, 2026
Time: 11:00 AM EDT
Duration: 1
  • <<
  • >>

Antibody titer is one of the most closely monitored metrics during upstream process development, but productivity alone doesn't tell the full story. As cell culture conditions change, critical quality attributes such as charge variants and aggregation can also shift, impacting product quality, downstream processing, and ultimately manufacturing success.

Join us for this educational webinar to learn how an integrated 2D-LC workflow combines rapid Protein A affinity titer analysis with charge variant (SCX) or aggregation (SEC) analysis from the same sample. Furthermore, we'll demonstrate how simultaneous monitoring of productivity and product quality provides earlier process insight, supports data-driven decision making, and helps accelerate biologics development.

Whether you're optimizing upstream processes, monitoring bioreactors, or developing scalable manufacturing workflows, you'll see how integrated analytical strategies can reduce analytical bottlenecks while providing more actionable information throughout development.

In this webinar you'll learn:

  • Discover how to measure antibody titer and critical quality attributes (CQA) from a single sample
  • Learn how integrated 2D-LC workflows provide faster, more actionable process insights
  • Understand how integrated analytics support consistent product quality and scalable biologics manufacturing
Senior Manager of
Product Management
Thermo Fisher Scientific
Image Mike Auerbach
Editor-in-Chief
American Pharmaceutical Review

Register Now

  • Please complete the following information to register for this webinar. If you already have an account, and the information will be filled out for you.
  • Please enter your mailing address.

  • I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com. I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.

    The webinar sponsors and American Pharmaceutical Review may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.